Clinical development of biosimilars: an evolving landscape
M Subramanyam - Bioanalysis, 2013 - Taylor & Francis
Biosimilars, or similar biological medicinal products, can provide a meaningful option for
patients and physicians provided they deliver the therapeutic value of a reference product at …
patients and physicians provided they deliver the therapeutic value of a reference product at …
Clinical development of biosimilars: an evolving landscape
M Subramanyam - Bioanalysis, 2013 - pubmed.ncbi.nlm.nih.gov
Biosimilars, or similar biological medicinal products, can provide a meaningful option for
patients and physicians provided they deliver the therapeutic value of a reference product at …
patients and physicians provided they deliver the therapeutic value of a reference product at …
Clinical development of biosimilars: an evolving landscape.
M Subramanyam - Bioanalysis, 2013 - europepmc.org
Biosimilars, or similar biological medicinal products, can provide a meaningful option for
patients and physicians provided they deliver the therapeutic value of a reference product at …
patients and physicians provided they deliver the therapeutic value of a reference product at …